Enzymotec (ENZY) Tops Q1 EPS by 3c

Enzymotec (NASDAQ: ENZY) reported Q1 EPS of $0.09, $0.03 better than the analyst estimate of $0.06. Revenue for the quarter came in at $12.25 million versus the consensus estimate of $12.1 million.

For earnings history and earnings-related data on Enzymotec (ENZY) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c